Bio-Imaging completes Theralys acquisition

Bio-Imaging Technologies of Newtown, PA, has acquired Theralys of Lyon, France, a provider of customized imaging services in the field of central nervous system disorders (CNS) and neurovascular diseases.

Theralys' proprietary image processing software is designed to introduce quantitative imaging markers in the design of clinical trials for neurovascular and CNS disorders, including stroke, secondary prevention drugs, multiple sclerosis, and dementia, including Alzheimer's disease.

With the acquisition, Bio-Imaging Technologies now has its Core Labs in Newtown, Lyon, and Leiden, Netherlands.

By staff writers
February 6, 2007

Related Reading

Bio-Imaging grows revenues, posts Q3 profit, November 9, 2006

Bio-Imaging to develop quantitative CTA software, March 30, 2006

DOBI teams up with Bio-Imaging, June 9, 2005

Copyright © 2007

Page 1 of 1247
Next Page